# FDA recall D-0015-2026

> **IntegraDose Compounding Services LLC** · Class I · drug recall initiated 2025-09-16.

## Product

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842  NDC 71139-0012-1

## Reason for recall

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0015-2026
- **Recalling firm:** IntegraDose Compounding Services LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-09-16
- **Report date:** 2025-10-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0015-2026

## Citation

> AI Analytics. FDA recall D-0015-2026. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0015-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*